#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8200	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2169	371.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	482	C	471	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8200	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2169	371.8	0	HET	.	.	.	C451T	.	451	451	C	683	683	C	430	C,T	318,103	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8200	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2169	371.8	0	HET	.	.	.	C207T	.	207	207	C	439	439	C	443	C,T	228,201	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	15286	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3540	427.1	0	.	n	.	0	T695C	SNP	695	695	T	1031	1031	C	469	C	462	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	15286	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3540	427.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1974	1974	G	477	G,A	458,7	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	15286	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3540	427.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2307	2307	C	410	C	400	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	15286	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3540	427.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2381	2381	A	454	A	449	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	15286	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3540	427.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2933	2933	C	430	C,T	416,8	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	15286	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3540	427.1	0	HET	.	.	.	C2402T	.	2402	2402	C	2738	2738	C	479	C,T	345,119	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1090	folP	855	855	100.0	folP.l15.c17.ctg.1	1485	72.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1024	1026	AGC	101;106;106	A;G;C	99;103;103	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3118	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3363	91.6	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	106;105;105	T;T,C;C	103;98,4;100	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3118	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3363	91.6	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	99;99;101	G;G,A;C	96;92,4;99	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3118	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3363	91.6	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	99;99;101	G;G,A;C	96;92,4;99	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	958	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1323	71.7	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	123;122;123	G;G;C	123;122;122	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	508	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	980	51.1	0	.	n	.	0	A197.	DEL	197	197	A	591	591	A	102	A	102	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2892	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3035	94.1	1	SNP	p	D86N	0	.	.	256	258	GAC	568	570	GAC	118;118;119	G;A;C	118;116;118	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2892	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3035	94.1	1	SNP	p	S87R	1	.	.	259	261	CGT	571	573	CGT	117;117;117	C,A;G;T	115,2;117;117	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2892	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3035	94.1	1	SNP	p	R87I	0	.	.	259	261	CGT	571	573	CGT	117;117;117	C,A;G;T	115,2;117;117	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2892	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3035	94.1	1	SNP	p	R87W	0	.	.	259	261	CGT	571	573	CGT	117;117;117	C,A;G;T	115,2;117;117	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2892	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3035	94.1	1	SNP	p	S88P	0	.	.	262	264	TCC	574	576	TCC	117;117;121	T;C;C	115;114;120	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2388	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2808	84.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1644	1646	GGC	117;116;115	G;G;C	115;114;114	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1239	1241	GCC	135;136;135	G;C;C	133;132;132	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1242	1244	ATG	134;133;134	A;T;G	133;132;130	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1254	1256	ACC	137;136;137	A,T;C;C	131,1;134;134	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1254	1256	ACC	137;136;137	A,T;C;C	131,1;134;134	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1755	1757	ACC	111;111;111	A;C;C	107;109;109	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1809	1811	GCG	110;113;112	G;C;G	109;112;110	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1809	1811	GCG	110;113;112	G;C;G	109;112;110	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1932	1934	GGT	88;86;85	G;G;T,C	85;85;81,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1941	1943	AGC	82;81;81	A,G;G;C	78,1;78;77	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2222	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2435	89.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1959	1961	CCG	73;74;74	C,CGG;C,G;G	64,1;65,1;61	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3320	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3153	104.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1613	1615	CCG	113;113;114	C;C,T;G	103;110,2;110	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1556	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1836	83.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	518	518	C	105	C	97	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1576	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1491	103.2	1	SNP	p	G120K	1	.	.	358	360	AAG	695	697	AAG	114;115;116	A,G;A,G;G,T	112,1;112,1;107,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1576	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1491	103.2	1	SNP	p	A121N	1	.	.	361	363	AAC	698	700	AAC	117;115;118	A,G;A,C;C	112,2;112,1;114	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1576	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1491	103.2	1	SNP	p	N121D	0	.	.	361	363	AAC	698	700	AAC	117;115;118	A,G;A,C;C	112,2;112,1;114	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	5532	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4876	112.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	662	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	927	70.4	1	SNP	p	V57M	1	.	.	169	171	ATG	462	464	ATG	133;133;131	A;T;G	133;131;129	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
